Related Experiment Videos
[Uterine leiomyoma: presentation of 2 cases with diffuse metastasis and a long clinical course]
Giornale Italiano Di Oncologia
|July 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A simple and reproducible prognostic index in luminal ER-positive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2011
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
[The use of ranitidine in antineoplastic polychemotherapy].
Giornale italiano di oncologia·1990
[Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].
Giornale italiano di oncologia·1990
[Ascites and carcinoma of the endometrium].
Giornale italiano di oncologia·1990
[Changes in performance status in patients with pulmonary carcinoma treated with mono-fractionation radiotherapy once a week].
Giornale italiano di oncologia·1990
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026